“…Anakinra has been utilized in a number of other conditions, including other monogenic autoinflammatory disorders (75), such as systemic-onset juvenile idiopathic arthritis (76,77), adult-onset Still disease (AOSD) (78,79), gout (80), polyarticular juvenile idiopathic arthritis (sJIA) (81), diabetes (82), heart disease (83-85), and chronic granulomatous disease (86), among many others (87). In these disorders, anakinra was well tolerated except for injectionsite reactions and a slight increase in nonserious viral respiratory infections.…”